• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples.

作者信息

O'Donnell Valerie B, Schebb Nils H, Milne Ginger L, Murphy Michael P, Thomas Christopher P, Steinhilber Dieter, Gelhaus Stacy L, Kühn Hartmut, Gelb Michael H, Jakobsson Per-Johan, Blair Ian A, Murphy Robert C, Freeman Bruce A, Brash Alan R, FitzGerald Garret A

机构信息

Systems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN, Cardiff, Wales, UK.

Chair of Food Chemistry, Faculty of Mathematics and Natural Sciences University of Wuppertal, Gausstraße 20, 42119, Wuppertal, Germany.

出版信息

Nat Commun. 2023 Nov 9;14(1):7172. doi: 10.1038/s41467-023-41766-w.

DOI:10.1038/s41467-023-41766-w
PMID:37945602
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10636151/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9adb/10636151/fdcf4edab1f8/41467_2023_41766_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9adb/10636151/8fd0f184ff21/41467_2023_41766_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9adb/10636151/fdcf4edab1f8/41467_2023_41766_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9adb/10636151/8fd0f184ff21/41467_2023_41766_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9adb/10636151/fdcf4edab1f8/41467_2023_41766_Fig2_HTML.jpg

相似文献

1
Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples.未能将标准检测限或定量限标准应用于特殊促消退介质分析会错误地判定它们在生物样品中的存在情况。
Nat Commun. 2023 Nov 9;14(1):7172. doi: 10.1038/s41467-023-41766-w.
2
Reply to: Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples.回复：未能将标准检测限或定量限标准应用于特殊促消退介质分析，会错误地描述它们在生物样品中的存在情况。
Nat Commun. 2023 Nov 10;14(1):7293. doi: 10.1038/s41467-023-41767-9.
3
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid.二十二碳六烯酸衍生的促解决脂质介质的潜在临床应用
Nutrients. 2023 Jul 26;15(15):3317. doi: 10.3390/nu15153317.
4
Specialized pro-resolving mediators as modulators of immune responses.特异性促解决介质作为免疫反应的调节剂。
Semin Immunol. 2022 Jan;59:101605. doi: 10.1016/j.smim.2022.101605. Epub 2022 Jun 2.
5
The role of specialized pro-resolving mediators in maternal-fetal health.特异性促解决介质在母婴健康中的作用。
Prostaglandins Leukot Essent Fatty Acids. 2017 Nov;126:98-104. doi: 10.1016/j.plefa.2017.09.017. Epub 2017 Sep 23.
6
The novel lipid mediator PD1: An overview of the structural elucidation, synthesis, biosynthesis and bioactions.新型脂质介质PD1：结构解析、合成、生物合成及生物活性概述
Prostaglandins Other Lipid Mediat. 2017 Nov;133:103-110. doi: 10.1016/j.prostaglandins.2017.06.003. Epub 2017 Jun 7.
7
Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1.解析炎症： RvD1 的合成、构象分配和生物评价。
Chemistry. 2019 Jan 28;25(6):1476-1480. doi: 10.1002/chem.201806029. Epub 2018 Dec 20.
8
Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects.健康受试者食用富含特定 resolving 脂质介质的海洋鱼油后药代动力学和脂质介质谱变化。
Int J Mol Sci. 2023 Nov 9;24(22):16143. doi: 10.3390/ijms242216143.
9
Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.神经炎症中的特异性促解决介质：研究概述及临床应用展望。
Molecules. 2022 Jul 28;27(15):4836. doi: 10.3390/molecules27154836.
10
Gram scale synthesis of specialized pro-resolving mediator 17(S)-HDHA using lipoxygenase enhanced by water-soluble reducing agent TCEP.使用由水溶性还原剂三(2-羧乙基)膦增强的脂氧合酶进行克级规模合成特殊促消退介质17(S)-氢过氧化二十二碳六烯酸。
Bioorg Med Chem Lett. 2016 Jan 15;26(2):343-345. doi: 10.1016/j.bmcl.2015.12.011. Epub 2015 Dec 7.

引用本文的文献

1
Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis.代谢功能障碍相关脂肪性肝病和肝纤维化中的花生四烯酸代谢
Hepatol Commun. 2025 Aug 29;9(9). doi: 10.1097/HC9.0000000000000802. eCollection 2025 Sep 1.
2
The potential of exogenous specialized pro-resolving mediators in protecting against sepsis-associated lung injury: a review.外源性特异性促分解介质在预防脓毒症相关肺损伤中的潜力：综述
Front Pharmacol. 2025 Jul 29;16:1622754. doi: 10.3389/fphar.2025.1622754. eCollection 2025.
3
Functional humanization of 15-lipoxygenase-1 (Alox15) protects mice from dextran sodium sulfate induced intestinal inflammation.

本文引用的文献

1
Steps Toward Minimal Reporting Standards for Lipidomics Mass Spectrometry in Biomedical Research Publications.生物医学研究出版物中脂质组学质谱分析最低报告标准的制定步骤。
Circ Genom Precis Med. 2020 Dec;13(6):e003019. doi: 10.1161/CIRCGEN.120.003019. Epub 2020 Nov 16.
2
Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis.促血 resolution 介质与滑膜病理学相关，并可预测类风湿关节炎对 DMARD 的反应性。
Nat Commun. 2020 Oct 27;11(1):5420. doi: 10.1038/s41467-020-19176-z.
3
Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes.
15-脂氧合酶-1（Alox15）的功能性人源化可保护小鼠免受葡聚糖硫酸钠诱导的肠道炎症。
Cell Mol Biol Lett. 2025 Jul 13;30(1):81. doi: 10.1186/s11658-025-00756-0.
4
From Fish Oil to Resolution: A Narrative Review on the Potential of SPM-Enriched Marine Oil for Exercise-Induced Muscle Damage Recovery.从鱼油到消退：关于富含消退素的海洋油对运动诱导的肌肉损伤恢复潜力的叙述性综述
Nutrients. 2025 Jun 16;17(12):2014. doi: 10.3390/nu17122014.
5
Stable Isotope Labeling in Bacteria Enables Characterization and Quantification of Frataxin Protein in a Friedreich's Ataxia Zebrafish Model.细菌中的稳定同位素标记可对弗里德赖希共济失调斑马鱼模型中的frataxin蛋白进行表征和定量分析。
Anal Chem. 2025 Jul 8;97(26):13779-13788. doi: 10.1021/acs.analchem.4c07095. Epub 2025 Jun 24.
6
Enhancing tofacitinib's therapeutic efficacy in murine arthritis with a synbiotic formulation comprising DSM 32963 and an Omega-3 fatty acid lysine salt.用包含DSM 32963和ω-3脂肪酸赖氨酸盐的合生元制剂提高托法替布在小鼠关节炎中的治疗效果。
Front Immunol. 2025 May 26;16:1540878. doi: 10.3389/fimmu.2025.1540878. eCollection 2025.
7
Reflections on Progress and Shaping the Future of Maternal and Child Health in Global Health Law.关于全球卫生法中母婴健康的进展与塑造未来的思考
J Law Med Ethics. 2025;53(S1):64-65. doi: 10.1017/jme.2025.11. Epub 2025 Mar 27.
8
Segregate Assessment of Data Validity from the More Complex Issue of Fraud.将数据有效性评估与更为复杂的欺诈问题区分开来。
J Law Med Ethics. 2025 Mar 21:1-3. doi: 10.1017/jme.2025.42.
9
The role of n-3-derived specialised pro-resolving mediators (SPMs) in microglial mitochondrial respiration and inflammation resolution in Alzheimer's disease.n-3衍生的特异性促消退介质（SPMs）在阿尔茨海默病小胶质细胞线粒体呼吸和炎症消退中的作用
Mol Neurodegener. 2025 Mar 21;20(1):35. doi: 10.1186/s13024-025-00824-1.
10
Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection.血小板12-脂氧合酶缺乏会加剧新型冠状病毒感染期间的炎症反应和疾病严重程度。
Proc Natl Acad Sci U S A. 2025 Mar 25;122(12):e2420441122. doi: 10.1073/pnas.2420441122. Epub 2025 Mar 18.
中性粒细胞消退素E1受体在2型糖尿病中的表达与功能
J Immunol. 2017 Jan 15;198(2):718-728. doi: 10.4049/jimmunol.1601543. Epub 2016 Dec 19.
4
Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation.消退素D3在关节炎中失调并减轻关节炎炎症。
J Immunol. 2016 Sep 15;197(6):2362-8. doi: 10.4049/jimmunol.1502268. Epub 2016 Aug 17.
5
Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis.消退素D1在炎性关节炎中的促消退及软骨保护作用
JCI Insight. 2016 Apr 21;1(5):e85922. doi: 10.1172/jci.insight.85922.
6
Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections.阐明随阿托伐他汀增加并清除感染的新型13系列消退素。
Nat Med. 2015 Sep;21(9):1071-5. doi: 10.1038/nm.3911. Epub 2015 Aug 3.
7
Identification of resolvin D2 receptor mediating resolution of infections and organ protection.鉴定介导感染消退和器官保护的消退素D2受体。
J Exp Med. 2015 Jul 27;212(8):1203-17. doi: 10.1084/jem.20150225. Epub 2015 Jul 20.
8
Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways.新型促消退和组织再生的消退素和保护素硫醚共轭途径。
FASEB J. 2015 May;29(5):2120-36. doi: 10.1096/fj.14-268441. Epub 2015 Feb 20.
9
Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.消退素D1通过抑制钙激活激酶途径来限制5-脂氧合酶的核定位和白三烯B4的合成。
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14530-5. doi: 10.1073/pnas.1410851111. Epub 2014 Sep 22.
10
Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.在人体组织中鉴定和特征分析促修复和促炎脂质介质。
Am J Physiol Cell Physiol. 2014 Jul 1;307(1):C39-54. doi: 10.1152/ajpcell.00024.2014. Epub 2014 Apr 2.